Method of prognosis
AssigneesRegion Midjylland, Aarhus Universitet
InventorsSøren Moestrup, Ruth Frikke-Schmidt, Anne Tybjaerg-Hansen, Holger J. Møller
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of soluble CD163 as a prognostic marker for the assessment of the risk for contracting a disorder, in particular for contracting diabetes and/or a liver disorder. The invention also relates to the use of CD163 as a prognostic marker for assessing lifetime expectancy.
Claims29
1-50. (canceled)
A method for assessing the likelihood of contracting a disorder, said method comprising determining the amount of soluble CD163 in a biological sample from an individual wherein a high level of soluble CD163 is indicative of an increased likelihood.
Dependencies are inferred from the claim text.